Winston & Strawn represented Roth Capital Partners LLC as placement agent in a registered direct offering of US$12.9 million of common stock by China Ritar Power Corp. China Ritar is a US publicly listed company with operations in China. Hong Kong-based partner and Chairman of Asia Practice Group Simon Luk and New York-based partner Eric Cohen led the Winston’s team to handle this cross-border transaction.

In the other transaction, Winston & Strawn represented Winner Medical Group Inc. (“Winner Medical”) in its migration of registration of securities from the OTCBB to the NYSE Amex. The migration involved a 1 for 2 reverse stock split of Winner Medical’s common stock. Winner Medical is a leading manufacturer and the largest exporter by volume in the medical dressing industry (medical and wound care products) in China. Its registration with the NYSE Amex became effective on October 8, 2009. Hong Kong-based partner and Chairman of Asia Practice Group Simon Luk led the Winston’s team to handle the migration.